Essex Investment Management’s Processa Pharmaceuticals PCSA Stock Holding History

Essex Investment Management’s Portfolio PCSA Stock Details PCSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5	Closed	-$5K	–	421
2022 Q3	$5K	Hold	5	–	–	﹤0.01%	395
2022 Q2	$6K	Buy	+5	New	+$6.85K	﹤0.01%	404
2022 Q1	–	Sell	-146	Closed	-$359K	–	413
2021 Q4	$359K	Sell	146 -3	-2%	-$9.3K	0.04%	287
2021 Q3	$637K	Buy	149 +3	+2%	+$10.3K	0.08%	252
2021 Q2	$597K	Hold	146	–	–	0.07%	268
2021 Q1	$795K	Sell	146 -4	-3%	-$18.6K	0.1%	256
2020 Q4	$494K	Buy	+150	New	+$416K	0.06%	289

Other funds holding PCSA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

CBA

Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Essex Investment Management's PCSA Position: Q4 2022 in Review

Essex Investment Management sold out of Processa Pharmaceuticals (PCSA) in Q4 2022, closing a stake of 5 shares — an estimated $5K sold.

Essex Investment Management first reported a position in PCSA in Q4 2020 and held it in 7 quarters. The position peaked at $795K in Q1 2021. 17 funds tracked by Wall St. Rank hold PCSA as of Q4 2022.

Essex Investment Management reported no remaining Processa Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Essex Investment Management sold 5 Processa Pharmaceuticals shares in Q4 2022, an estimated $5K.
Essex Investment Management first reported a position in Processa Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Essex Investment Management's Processa Pharmaceuticals position peaked at $795K in Q1 2021.
17 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q4 2022.

Based on Essex Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.